Hemostasis depends on a sufficient quantity of well-functioning platel
ets. Platelets adhere to the damaged vessel wall via surface glycoprot
eins that couple to collagen fibers and different adhesive proteins in
the wound. The contact triggers activation cascades in the cell, lead
ing to release and secretion of mediators that activate adjacent plate
lets. Further activation results in exposure of binding sites for fibr
inogen that couples one platelet to another and to alterations in the
plasma membrane that generate a procoagulant surface thereby facilitat
ing blood coagulation. A number of congenital abnormalities in these p
athways have now been characterized, offering further insight in the r
ole of platelets in the cessation of bleeding and providing a basis fo
r future corrective therapy.